期刊
STEM CELL RESEARCH
卷 31, 期 -, 页码 186-192出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.scr.2018.08.003
关键词
Human pluripotent stem cells; Embryonic stem cells; Single-cell cloning; Induced pluripotent stem cells; hPSCs; hESCs; Genome engineering; CRISPR-Cas9
资金
- NCI Cancer Center Support Grant [P30 CA091842]
- American Lebanese Syrian Associated Charities
The availability of human pluripotent stem cells (hPSCs) and progress in genome engineering technology have altered the way we approach scientific research and drug development screens. Unfortunately, the procedures for genome editing of hPSCs often subject cells to harsh conditions that compromise viability: a major problem that is compounded by the innate challenge of single-cell culture. Here we describe a generally applicable workflow that supports single-cell cloning and expansion of hPSCs after genome editing and single-cell sorting. Stem-Flex and RevitaCell supplement, in combination with Geltrex or Vitronectin (VN), promote reliable single-cell growth in a feeder-free and defined environment. Characterization of final genome-edited clones reveals that pluripotency and normal karyotype are retained following this single-cell culture protocol. This time-efficient and simplified culture method paves the way for high-throughput hPSC culture and will be valuable for both basic research and clinical applications.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据